Corebridge Financial’s G1 Therapeutics GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-26,547
Closed -$60.8K – 3052
2024
Q2
$60.8K Buy
+26,547
New +$101K ﹤0.01% 2838

Corebridge Financial's GTHX Position: Q3 2024 in Review

Corebridge Financial sold out of G1 Therapeutics (GTHX) in Q3 2024, closing a stake of 26,547 shares — an estimated $60.8K sold.

Corebridge Financial first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $60.8K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Corebridge Financial reported no remaining G1 Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Corebridge Financial sold 26,547 G1 Therapeutics shares in Q3 2024, an estimated $60.8K.
  • Corebridge Financial first reported a position in G1 Therapeutics in Q2 2024 and held it in 1 quarter.
  • Corebridge Financial's G1 Therapeutics position peaked at $60.8K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics as of Q3 2024.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.